Randomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
PRIMARY OBJECTIVE• To compare time to next treatment (TTNT), defined as the time from randomization toinitiation of new lymphoma directed systemic therapy, between participants withpreviously untreated, low tumor burden follicular lymphoma treated with epcoritamabversus watchful waiting.
Epistemonikos ID: 42dcbe2da779cb39fed4325d3db3e0ec39b43845
First added on: Aug 26, 2026